Cellectar Biosciences, Inc. — Director's Dealing 2014

Aug 22, 2014

SEC Form 3/A — Form 3/A

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2014-08-14

Reporting Person: NEIS JOHN (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.00001 per share	363715	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Purchase Warrant (right to buy)	$10.00	2015-02-20	Common Stock (55000)		Indirect
Stock Purchase Warrant (right to buy)	$12.00	2016-12-01	Common Stock (55000)		Indirect
Stock Purchase Warrant (right to buy)	$15.00	2016-03-31	Common Stock (100000)		Indirect

Footnotes

F1: These shares were omitted from the reporting person's original Form 3.

F2: These securities are held by Venture Investors Early Stage Fund IV Limited Partnership and Advantage Capital Wisconsin Partners I, Limited Partnership. VIESF IV GP LLC is the general partner of Venture Investors Early Stage Fund IV Limited Partnership and Venture Investors LLC is the submanager and special limited partner of Advantage Capital Wisconsin Partners I, Limited Partnership. The investment decisions of VIESF IV GP LLC and Venture Investors LLC are made collectively by seven managers, including the reporting person. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

F3: Shares of Common Stock underlying this stock purchase warrant were reported as 2,750 in the reporting person's original Form 3.

F4: This stock purchase warrant was omitted from the reporting person's original Form 3.

F5: Shares of Common Stock underlying this stock purchase warrant were reported as 55,000 in the reporting person's original Form 3.